Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function
- 11 July 2008
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 51 (5), 652-656
- https://doi.org/10.1002/pbc.21673
Abstract
Background Children with Fanconi anemia (FA) tend to have short stature, mild thyrotropin (TSH) elevation, and borderline low free thyroxine (FT4). Objective was to examine whether thyroid hormone therapy improves linear growth in children with FA and borderline thyroid function tests Procedure Thyroid function tests were performed in 63 children with FA. Eight subjects participated in a random order, double‐blind, cross‐over treatment for 7 months with levothyroxine and for 7 months with placebo. Monitoring included growth measurements and laboratory assays at 1, 4 and 7 months of each phase. A 1 month lead in/wash out period was excluded from analysis of each treatment phase. Results The majority (63%) of FA children had borderline thyroid function tests. All eight FA subjects enrolled in the treatment study had FT4 in the lowest third of the normal range of 0.8–1.8 ng/dL (10.3–23.2 pmol/L) [FT4 0.9 ± 0.1 ng/dL (mean ± SD), range 0.8–1.2 ng/dL (10.3–15.4 pmol/L)]. TSH (optimal range 0.5–3 mU/L) was borderline elevated in six of eight subjects (4.0 ± 1.5 mU/L, 1.9–7.3 mU/L). Growth velocity was slow at baseline and improved significantly during the thyroid phase compared to the placebo phase (2.1 ± 1.2 cm/year vs. 5.4 ± 1.7 cm/year, P < 0.05). Conclusions Thyroid hormone therapy is safe and may improve linear growth velocity in children with FA who have borderline thyroid function. Subtle hypothyroidism has importance for growth in children. Whether thyroid hormone treatment improves adult height in these children remains to be elucidated. Pediatr Blood Cancer 2008;51:652–656.This publication has 20 references indexed in Scilit:
- Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretionPediatric Blood & Cancer, 2008
- Small pituitary size in children with Fanconi AnemiaPediatric Blood & Cancer, 2007
- Subclinical hypothyroidismCurrent Opinion in Endocrinology, Diabetes and Obesity, 2007
- Update of Newborn Screening and Therapy for Congenital HypothyroidismPEDIATRICS, 2006
- Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescenceBone Marrow Transplantation, 2006
- Height improvement by L-thyroxinetreatment in subclinical hypothyroidismPediatrics International, 2003
- Diagnosis of Fanconi anemia in patients without congenital malformations: An international Fanconi anemia registry studyAmerican Journal of Medical Genetics, 1997
- Short stature, Fanconi's anaemia, and risk of leukaemia after growth hormone therapyThe Lancet, 1994
- Endocrine studies in Fanconi's anaemia. Report of 4 cases.Archives of Disease in Childhood, 1978
- Fanconi's aplastic anaemia with short stature. Absence of response to human growth hormone.Archives of Disease in Childhood, 1975